Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Musculoskeletal and connective tissue disorders NEC
ADR ID BADD_A02907
ADR Hierarchy
15      Musculoskeletal and connective tissue disorders
15.03      Musculoskeletal and connective tissue disorders NEC
Description Not Available
MedDRA Code 10028393
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00223Belatacept--
BADD_D00224Belimumab--
BADD_D00225Belinostat0.000392%
BADD_D00228Benazepril hydrochloride--
BADD_D00229Benazeprilat--
BADD_D00230Bendamustine0.000224%
BADD_D00231Bendamustine hydrochloride--
BADD_D00233Benicar hydrochlorothiazide--
BADD_D00254Bepridil--
BADD_D00260Betamethasone--
BADD_D00261Betamethasone dipropionate--
BADD_D00263Betaxolol--
BADD_D00268Bevacizumab--
BADD_D00269Bexarotene--
BADD_D00270Bezafibrate--
BADD_D00271Bicalutamide0.013358%
BADD_D00277Bisoprolol0.003140%
BADD_D00278Bisoprolol fumarate--
BADD_D00279Bivalirudin--
BADD_D00280Bleomycin--
BADD_D00282Blinatumomab--
BADD_D00283Boceprevir--
BADD_D00284Bortezomib0.000504%
BADD_D00285Bosentan0.009194%
BADD_D00286Bosutinib0.009592%
BADD_D00287Bosutinib monohydrate--
BADD_D00289Botulinum neurotoxin a/b immune globulin (human)--
BADD_D00290Botulinum toxin type a--
BADD_D00291Brentuximab vedotin--
BADD_D00293Brexpiprazole0.002483%
The 5th Page    First    Pre   5 6 7 8 9    Next   Last    Total 48 Pages